Gilead Sciences, Inc.

NASDAQ:GILD  
62.96
+0.51 (+0.82%)
Other Pre-Announcement

Gilead Sciences Q2 Non-GAAP Earnings Per Share $1.58

Published: 08/02/2022 21:09 GMT
Gilead Sciences, Inc. (GILD) - Gilead Sciences Announces Second Quarter 2022 Financial Results.
Q2 Non-GAAP Earnings per Share $1.58.
Q2 Earnings per Share $0.91.
Total Q2 2022 Revenue Increased 1% to $6.3 Billion Compared to Same Period in 2021.
Total Q2 2022 Product Sales Were $6.1 Billion, Flat Compared to Same Period in 2021.
Total Product Sales, Excluding Veklury, Increased 7% to $5.7 Billion in Q2 of 2022.
Sees FY Total Product Sales Between $24.5 Billion and $25.0 Billion, Compared to $23.8 Billion and $24.3 Billion Previously.
Sees FY Earnings per Share Between $2.90 and $3.30, Compared to $3.00 and $3.50 Previously.
Sees FY Non-GAAP Earnings per Share Between $6.35 and $6.75, Compared to $6.20 and $6.70 Previously.
Sees FY Total Veklury Sales of Approximately $2.5 Billion, Compared to Approximately $2.0 Billion Previously.
Veklury Sales Decreased by 46% to $445 Million for Q2 of 2022 Compared to Same Period in 2021.
Q2 Earnings per Share View $1.52, Revenue View $5.85 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $6.56 -- Refinitiv Ibes Data (analyst estimates).